Felzartamab (anti-CD38) in patients with IgA Nephropathy-interim results from the IGNAZ study

被引：0
|
作者：
Floege, Juergen [1 ]
Lafayette, Richard [2 ]
Barratt, Jonathan [3 ]
Schwartz, Brian [4 ]
Manser, Paul T. [4 ]
Patel, Uptal D. [4 ]
Pineda, Lilia [4 ]
Faulhaber, Nicola [5 ]
Boxhammer, Rainer [5 ]
Haertle, Stefan [5 ]
Thakur, Anjali [5 ]
Barbour, Sean [6 ]
机构：
[1] RWTH Aachen Univ Hosp, Div Nephrol & Cardiol, Aachen, Germany
[2] Stanford Glomerular Dis Ctr, Palo Alto, CA USA
[3] Univ Leicester, Leicester, Leics, England
[4] Human Immunol Biosci Inc, San Francisco, CA USA
[5] MorphoSys AG, Planegg, Germany
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
425
引用
收藏
页码：I252 / I253
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study
    Perkovic, Vlado
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Rizk, Dana V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I255 - I256
  • [32] The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
    Wang, Xiaoqian
    Dahl, Martin
    Nguyen, Doan
    Jenks, Scott
    Cashman, Kevin
    Lee, F. Eun-Hyung
    McLean, Lachy
    Sanz, Ignacio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [33] Case Study: Interference With Compatibility Testing Caused by Anti-CD38 Humanized Monoclonal Antibody (Isatuximab)
    Perzan, Stacy
    Gresens, Christopher J.
    Almaz, Bassam
    Doane, Rebecca
    Veneman, Susan
    [J]. TRANSFUSION, 2019, 59 : 135A - 136A
  • [34] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    [J]. BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [35] Preliminary Results from a Phase 1b Study of TAK-079, an Investigational Anti-CD38 Monoclonal Antibody (mAb) in Patients with Relapsed/ Refractory Multiple Myeloma (RRMM)
    Krishnan, Amrita Y.
    Patel, Krina K.
    Hari, Parameswaran
    Jagannath, Sundar
    Niesvizky, Ruben
    Silbermann, Rebecca W.
    Berg, Deborah
    Lin, Jianchang
    Fedyk, Eric Robert
    Palumbo, Antonio
    Stockerl-Goldstein, Keith E.
    [J]. BLOOD, 2019, 134
  • [36] Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy
    Venglar, Ondrej
    Kapustova, Veronika
    Anilkumar Sithara, Anjana
    Zihala, David
    Muronova, Ludmila
    Sevcikova, Tereza
    Vrana, Jan
    Vdovin, Alexander
    Radocha, Jakub
    Krhovska, Petra
    Hrdinka, Matous
    Turjap, Michal
    Popkova, Tereza
    Chyra, Zuzana
    Broskevicova, Lucie
    Simicek, Michal
    Koristek, Zdenek
    Hajek, Roman
    Jelinek, Tomas
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1439 - 1449
  • [37] FELZARTAMAB IN PATIENTS WITH ANTI-PHOSPHOLIPASE A2 RECEPTOR AUTOANTIBODYPOSITIVE (ANTI-PLA2R AB+) MEMBRANOUS NEPHROPATHY (MN): PRELIMINARY RESULTS FROM THE M-PLACE STUDY
    Rovin, Brad H.
    Adler, Sharon G.
    Hoxha, Elion
    Sprangers, Ben
    Stahl, Rolf
    Wetzels, Jack F. M.
    Jauch-Lembach, Julia
    Griese, Janine
    Boxhammer, Rainer
    Xu, Lei
    Hartle, Stefan
    Ronco, Pierre M.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S3 - S3
  • [38] Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy
    Mohyuddin, Ghulam Rehman
    Chakraborty, Rajshekhar
    Calip, Gregory
    Ascha, Mustafa S.
    Wang, Xiaoliang
    Rubinstein, Samuel
    Tuchman, Sascha A.
    Costa, Luciano J.
    Haaland, Benjamin
    Giri, Smith
    Mian, Hira S.
    Fonseca, Rafael
    Sborov, Douglas W.
    [J]. BLOOD, 2022, 140 : 5223 - 5224
  • [39] Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus
    Alexander, Tobias
    Ostendorf, Lennard
    Biesen, Robert
    Schneider, Udo
    Burmester, Gerd R.
    Hiepe, Falk
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (11) : 1497 - 1499
  • [40] Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
    Chia-Yu Chiu
    Krina Patel
    Sheeba K. Thomas
    Fareed Khawaja
    Natalie J. M. Dailey Garnes
    Hans C. Lee
    Maro Ohanian
    Ying Jiang
    Lan S. Wang
    Jessica P. Hwang
    Harrys A. Torres
    [J]. Hepatology International, 2023, 17 : 509 - 511
12345